The utility of next-generation sequencing in gene discovery for mutation-negative patients with Rett syndrome

Frontiers in Cellular Neuroscience

Volumn 9, Issue JULY, 2015, Pages

  Gold, Wendy Anne ^a,b   Christodoulou, John ^a,b,c  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Intellectual disability; Massively parallel sequencing; Mutation; Next generation sequencing; Rett syndrome

Indexed keywords

ARTICLE; DNA SEQUENCE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; INTELLECTUAL IMPAIRMENT; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NERVE CELL PLASTICITY; NEXT GENERATION SEQUENCING; RETT SYNDROME; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84937402093     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00266     Document Type: Article

References (54)

1. Amir, R. E., Fang, P., Yu, Z., Glaze, D. G., Percy, A. K., Zoghbi, H. Y., et al. (2005). Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome. J. Med. Genet. 42, e15. doi: 10.1136/jmg.2004.026161
2. Armani, R., Archer, H., Clarke, A., Vasudevan, P., Zweier, C., Ho, G., et al. (2012). Transcription factor 4 and myocyte enhancer factor 2C mutations are not common causes of Rett syndrome. Am. J. Med. Genet. A 158A, 713-719. doi:10.1002/ajmg.a.34206
3. Armstrong, D., Dunn, J. K., Antalffy, B., and Trivedi, R. (1995). Selective dendritic alterations in the cortex of Rett syndrome. J. Neuropathol. Exp. Neurol. 54, 195-201. doi:10.1097/00005072-199503000-00006
4. Armstrong, D. D., Dunn, K., and Antalffy, B. (1998). Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J. Neuropathol. Exp. Neurol. 57, 1013-1017. doi:10.1097/00005072-199811000-00003
5. Asaka, Y., Jugloff, D. G., Zhang, L., Eubanks, J. H., and Fitzsimonds, R. M. (2006). Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol. Dis. 21, 217-227. doi:10.1016/j.nbd.2005.07.005
6. Bahi-Buisson, N., Kaminska, A., Boddaert, N., Rio, M., Afenjar, A., Gerard, M., et al. (2008). The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia 49, 1027-1037. doi:10.1111/j.1528-1167.2007.01520.x
7. Bartholdi, D., Klein, A., Weissert, M., Koenig, N., Baumer, A., Boltshauser, E., et al. (2006). Clinical profiles of four patients with Rett syndrome carrying a novel exon 1 mutation or genomic rearrangement in the MECP2 gene. Clin. Genet. 69, 319-326. doi:10.1111/j.1399-0004.2006.00604.x
8. Bauman, M. L., Kemper, T. L., and Arin, D. M. (1995). Microscopic observations of the brain in Rett syndrome. Neuropediatrics 26, 105-108. doi:10.1055/s-2007-979737
9. Belichenko, P. V., Wright, E. E., Belichenko, N. P., Masliah, E., Li, H. H., Mobley, W. C., et al. (2009). Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J. Comp. Neurol. 514, 240-258. doi:10.1002/cne.22009
10. Bellos, E., and Coin, L. J. (2014). cnvOffSeq: detecting intergenic copy number variation using off-target exome sequencing data. Bioinformatics 30, i639-i645. doi:10.1093/bioinformatics/btu475
11. Chahrour, M., and Zoghbi, H. Y. (2007). The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422-437. doi:10.1016/j.neuron.2007.10.001
12. Christodoulou, J., Grimm, A., Maher, T., and Bennetts, B. (2003). RettBASE: the IRSA MECP2 variation database-a new mutation database in evolution. Hum. Mutat. 21, 466-472. doi:10.1002/humu.10194
13. Christodoulou, J., and Weaving, L. S. (2003). MECP2 and beyond: phenotype-genotype correlations in Rett syndrome. J. Child Neurol. 18, 669-674. doi:10.1177/08830738030180100901
14. Chunshu, Y., Endoh, K., Soutome, M., Kawamura, R., and Kubota, T. (2006). A patient with classic Rett syndrome with a novel mutation in MECP2 exon 1. Clin. Genet. 70, 530-531. doi:10.1111/j.1399-0004.2006.00712.x
15. Emberger, W., Windpassinger, C., Petek, E., Kroisel, P. M., and Wagner, K. (2000). Assignment of the human GABAA receptor delta-subunit gene (GABRD) to chromosome band 1p36.3 distal to marker NIB1364 by radiation hybrid mapping. Cytogenet. Cell Genet. 89, 281-282. doi:10.1159/000015636
16. Evans, J. C., Archer, H. L., Colley, J. P., Ravn, K., Nielsen, J. B., Kerr, A., et al. (2005a). Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur. J. Hum. Genet. 13, 1113-1120. doi:10.1038/sj.ejhg.5201451
17. Evans, J. C., Archer, H. L., Whatley, S. D., Kerr, A., Clarke, A., and Butler, R. (2005b). Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls. Eur. J. Hum. Genet. 13, 124-126. doi:10.1038/sj.ejhg.5201270
18. Fehr, S., Wilson, M., Downs, J., Williams, S., Murgia, A., Sartori, S., et al. (2013). The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy. Eur. J. Hum. Genet. 21, 266-273. doi:10.1038/ejhg.2012.156
19. Fukuda, T., Yamashita, Y., Nagamitsu, S., Miyamoto, K., Jin, J. J., Ohmori, I., et al. (2005). Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms. Brain Dev. 27, 211-217. doi:10.1016/j.braindev.2004.06.003
20. Gianakopoulos, P. J., Zhang, Y., Pencea, N., Orlic-Milacic, M., Mittal, K., Windpassinger, C., et al. (2012). Mutations in MECP2 exon 1 in classical Rett patients disrupt MECP2_e1 transcription, but not transcription of MECP2_e2. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B, 210-216. doi:10.1002/ajmg.b.32015
21. Gilissen, C., Hehir-Kwa, J. Y., Thung, D. T., van de Vorst, M., van Bon, B. W., Willemsen, M. H., et al. (2014). Genome sequencing identifies major causes of severe intellectual disability. Nature 511, 344-347. doi:10.1038/nature13394
22. Grillo, E., Lo Rizzo, C., Bianciardi, L., Bizzarri, V., Baldassarri, M., Spiga, O., et al. (2013). Revealing the complexity of a monogenic disease: Rett syndrome exome sequencing. PLoS ONE 8:e56599. doi:10.1371/journal.pone.0056599
23. Guy, J., Gan, J., Selfridge, J., Cobb, S., and Bird, A. (2007). Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143-1147. doi:10.1126/science.1138389
24. Hagberg, B., Aicardi, J., Dias, K., and Ramos, O. (1983). A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann. Neurol. 14, 471-479. doi:10.1002/ana.410140412
25. Hayflick, S. J., Kruer, M. C., Gregory, A., Haack, T. B., Kurian, M. A., Houlden, H. H., et al. (2013). beta-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain 136, 1708-1717. doi:10.1093/brain/awt095
26. Kato, T., Morisada, N., Nagase, H., Nishiyama, M., Toyoshima, D., Nakagawa, T., et al. (2015). Somatic mosaicism of a CDKL5 mutation identified by next-generation sequencing. Brain Dev. doi:10.1016/j.braindev.2015.03.002
27. Kishi, N., and Macklis, J. D. (2004). MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol. Cell. Neurosci. 27, 306-321. doi:10.1016/j.mcn.2004.07.006
28. Klauck, S. M., Lindsay, S., Beyer, K. S., Splitt, M., Burn, J., and Poustka, A. (2002). A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the Ppm-X syndrome. Am. J. Hum. Genet. 70, 1034-1037. doi:10.1086/339553
29. Kriaucionis, S., and Bird, A. (2004). The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res. 32, 1818-1823. doi:10.1093/nar/gkh349
30. Lonetti, G., Angelucci, A., Morando, L., Boggio, E. M., Giustetto, M., and Pizzorusso, T. (2010). Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol. Psychiatry 67, 657-665. doi:10.1016/j.biopsych.2009.12.022
31. Mnatzakanian, G. N., Lohi, H., Munteanu, I., Alfred, S. E., Yamada, T., Macleod, P. J., et al. (2004). A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat. Genet. 36, 339-341. doi:10.1038/ng1327
32. Moretti, P., Levenson, J. M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B., et al. (2006). Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci. 26, 319-327. doi:10.1523/JNEUROSCI.2623-05.2006
33. Neul, J. L., Fang, P., Barrish, J., Lane, J., Caeg, E. B., Smith, E. O., et al. (2008). Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 70, 1313-1321. doi:10.1212/01.wnl.0000291011.54508.aa
34. Neul, J. L., Kaufmann, W. E., Glaze, D. G., Christodoulou, J., Clarke, A. J., Bahi-Buisson, N., et al. (2010). Rett syndrome: revised diagnostic criteria and nomenclature. Ann. Neurol. 68, 944-950. doi:10.1002/ana.22124
35. Okamoto, N., Ikeda, T., Hasegawa, T., Yamamoto, Y., Kawato, K., Komoto, T., et al. (2014a). Early manifestations of BPAN in a pediatric patient. Am. J. Med. Genet. A 164A, 3095-3099. doi:10.1002/ajmg.a.36779
36. Okamoto, N., Miya, F., Tsunoda, T., Kato, M., Saitoh, S., Yamasaki, M., et al. (2014b). Targeted next-generation sequencing in the diagnosis of neurodevelopmental disorders. Clin. Genet. doi:10.1111/cge.12492
37. Pelka, G. J., Watson, C. M., Christodoulou, J., and Tam, P. P. (2005). Distinct expression profiles of Mecp2 transcripts with different lengths of 3'UTR in the brain and visceral organs during mouse development. Genomics 85, 441-452. doi:10.1016/j.ygeno.2004.12.002
38. Percy, A. K. (2008). Rett syndrome: recent research progress. J. Child Neurol. 23, 543-549. doi:10.1177/0883073807309786
39. Petel-Galil, Y., Benteer, B., Galil, Y. P., Zeev, B. B., Greenbaum, I., Vecsler, M., et al. (2006). Comprehensive diagnosis of Rett’s syndrome relying on genetic, epigenetic and expression evidence of deficiency of the methyl-CpG-binding protein 2 gene: study of a cohort of Israeli patients. J. Med. Genet. 43, e56. doi:10.1136/jmg.2006.041285
40. Philippe, C., Amsallem, D., Francannet, C., Lambert, L., Saunier, A., Verneau, F., et al. (2010). Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females. J. Med. Genet. 47, 59-65. doi:10.1136/jmg.2009.067355
41. Quenard, A., Yilmaz, S., Fontaine, H., Bienvenu, T., Moncla, A., des Portes, V., et al. (2006). Deleterious mutations in exon 1 of MECP2 in Rett syndrome. Eur. J. Med. Genet. 49, 313-322. doi:10.1016/j.ejmg.2005.11.002
42. Ravn, K., Nielsen, J. B., and Schwartz, M. (2005). Mutations found within exon 1 of MECP2 in Danish patients with Rett syndrome. Clin. Genet. 67, 532-533. doi:10.1111/j.1399-0004.2005.00444.x
43. Rett, A. (1966). [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. Wien. Med. Wochenschr. 116, 723-726.
44. Rosas-Vargas, H., Bahi-Buisson, N., Philippe, C., Nectoux, J., Girard, B., N’Guyen Morel, M. A., et al. (2008). Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathy. J. Med. Genet. 45, 172-178. doi:10.1136/jmg.2007.053504
45. Rosenfeld, J. A., Crolla, J. A., Tomkins, S., Bader, P., Morrow, B., Gorski, J., et al. (2010). Refinement of causative genes in monosomy 1p36 through clinical and molecular cytogenetic characterization of small interstitial deletions. Am. J. Med. Genet. A 152A, 1951-1959. doi:10.1002/ajmg.a.33516
46. Saitsu, H., Nishimura, T., Muramatsu, K., Kodera, H., Kumada, S., Sugai, K., et al. (2013). De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat. Genet. 45, 445-449. doi:10.1038/ng.2562
47. Saunders, C. J., Minassian, B. E., Chow, E. W., Zhao, W., and Vincent, J. B. (2009). Novel exon 1 mutations in MECP2 implicate isoform MeCP2_e1 in classical Rett syndrome. Am. J. Med. Genet. A 149A, 1019-1023. doi:10.1002/ajmg.a.32776
48. Saxena, A., de Lagarde, D., Leonard, H., Williamson, S. L., Vasudevan, V., Christodoulou, J., et al. (2006). Lost in translation: translational interference from a recurrent mutation in exon 1 of MECP2. J. Med. Genet. 43, 470-477. doi:10.1136/jmg.2005.036244
49. Suter, B., Treadwell-Deering, D., Zoghbi, H. Y., Glaze, D. G., and Neul, J. L. (2014). Brief report: MECP2 mutations in people without Rett syndrome. J. Autism Dev. Disord. 44, 703-711. doi:10.1007/s10803-013-1902-z
50. Swanberg, S. E., Nagarajan, R. P., Peddada, S., Yasui, D. H., and Lasalle, J. M. (2009). Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism. Hum. Mol. Genet. 18, 525-534. doi:10.1093/hmg/ddn380
51. Watson, P., Black, G., Ramsden, S., Barrow, M., Super, M., Kerr, B., et al. (2001). Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J. Med. Genet. 38, 224-228. doi:10.1136/jmg.38.4.224
52. Williamson, S. L., and Christodoulou, J. (2006). Rett syndrome: new clinical and molecular insights. Eur. J. Hum. Genet. 14, 896-903. doi:10.1038/sj.ejhg.5201580
53. Windpassinger, C., Kroisel, P. M., Wagner, K., and Petek, E. (2002). The human gamma-aminobutyric acid A receptor delta (GABRD) gene: molecular characterisation and tissue-specific expression. Gene 292, 25-31. doi:10.1016/S0378-1119(02)00649-2
54. Zhang, L., He, J., Jugloff, D. G., and Eubanks, J. H. (2008). The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus 18, 294-309. doi:10.1002/hipo.20389